• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米技术对药物递送的影响。

Impact of nanotechnology on drug delivery.

作者信息

Farokhzad Omid C, Langer Robert

机构信息

Laboratory of Nanomedicine and Biomaterials and Department of Anesthesiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.

出版信息

ACS Nano. 2009 Jan 27;3(1):16-20. doi: 10.1021/nn900002m.

DOI:10.1021/nn900002m
PMID:19206243
Abstract

Nanotechnology is the engineering and manufacturing of materials at the atomic and molecular scale. In its strictest definition from the National Nanotechnology Initiative, nanotechnology refers to structures roughly in the 1-100 nm size regime in at least one dimension. Despite this size restriction, nanotechnology commonly refers to structures that are up to several hundred nanometers in size and that are developed by top-down or bottom-up engineering of individual components. Herein, we focus on the application of nanotechnology to drug delivery and highlight several areas of opportunity where current and emerging nanotechnologies could enable entirely novel classes of therapeutics.

摘要

纳米技术是在原子和分子尺度上对材料进行工程设计和制造。根据美国国家纳米技术计划最严格的定义,纳米技术是指至少在一个维度上尺寸大致在1至100纳米范围内的结构。尽管有这个尺寸限制,但纳米技术通常指的是尺寸达数百纳米且通过单个组件的自上而下或自下而上工程开发的结构。在此,我们重点关注纳米技术在药物递送方面的应用,并突出当前和新兴纳米技术能够催生全新治疗方法的几个机遇领域。

相似文献

1
Impact of nanotechnology on drug delivery.纳米技术对药物递送的影响。
ACS Nano. 2009 Jan 27;3(1):16-20. doi: 10.1021/nn900002m.
2
Nanotechnology-based drug delivery for cancer.基于纳米技术的癌症药物递送
Technol Cancer Res Treat. 2005 Aug;4(4):407-16. doi: 10.1177/153303460500400408.
3
Nanocarrier Based Advances in Drug Delivery to Tumor: An Overview.基于纳米载体的肿瘤药物递释系统的研究进展概述。
Curr Drug Targets. 2018;19(13):1498-1518. doi: 10.2174/1389450119666180131105822.
4
Engineering DNA scaffolds for delivery of anticancer therapeutics.用于递送抗癌治疗药物的工程化DNA支架
Biomater Sci. 2015 Jul;3(7):1018-24. doi: 10.1039/c4bm00459k. Epub 2015 Feb 25.
5
Bio-inspired chimeric drug delivery nano systems (Chi-DDnSs): their fractal hologram and regulatory aspects.仿生嵌合药物递送纳米系统(Chi-DDnSs):它们的分形全息图及调控方面
Adv Exp Med Biol. 2015;822:199-200. doi: 10.1007/978-3-319-08927-0_23.
6
The fractal analysis as a complementary approach to predict the stability of drug delivery nano systems (DDnSs) in aqueous and biological media: a regulatory proposal or a dream?分形分析作为一种补充方法用于预测药物递送纳米系统(DDnSs)在水性和生物介质中的稳定性:是一项监管提议还是一个梦想?
Adv Exp Med Biol. 2015;822:211-2. doi: 10.1007/978-3-319-08927-0_27.
7
Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system.纳米技术在治疗学中的应用:聚焦于纳米粒子作为药物传递系统。
Nanomedicine (Lond). 2012 Aug;7(8):1253-71. doi: 10.2217/nnm.12.87.
8
Nanostructure-mediated drug delivery.纳米结构介导的药物递送
Nanomedicine. 2005 Mar;1(1):22-30. doi: 10.1016/j.nano.2004.11.009.
9
Nanotechnology platforms and physiological challenges for cancer therapeutics.用于癌症治疗的纳米技术平台及生理挑战
Nanomedicine. 2007 Jun;3(2):103-10. doi: 10.1016/j.nano.2006.12.002. Epub 2007 Apr 17.
10
Advances and challenges of nanotechnology-based drug delivery systems.基于纳米技术的药物递送系统的进展与挑战
Expert Opin Drug Deliv. 2007 Nov;4(6):621-33. doi: 10.1517/17425247.4.6.621.

引用本文的文献

1
Current perspectives and global trends of nanotechnology in advanced breast cancer: a bibliometric and visualized analysis.纳米技术在晚期乳腺癌中的当前观点与全球趋势:一项文献计量学与可视化分析
Discov Oncol. 2025 Aug 29;16(1):1652. doi: 10.1007/s12672-025-03260-1.
2
A novel chitosan agarose nanocopper composite film (Cs/Agr/Cu-CuO NPs) using K Y 401431: preparation, characterization and evaluation of their antibacterial activity.一种使用K Y 401431制备的新型壳聚糖琼脂糖纳米铜复合膜(Cs/Agr/Cu-CuO NPs):其制备、表征及抗菌活性评估
3 Biotech. 2025 Sep;15(9):306. doi: 10.1007/s13205-025-04471-7. Epub 2025 Aug 20.
3
Revolutionizing Breast Cancer Therapeutics: Intersecting Frontiers of Precision Medicine, Nanotechnology, and Drug Delivery Innovations.
变革乳腺癌治疗:精准医学、纳米技术与药物递送创新的交叉前沿
Curr Treat Options Oncol. 2025 Aug 19. doi: 10.1007/s11864-025-01343-3.
4
Bioactive Nanomaterials: Comprehensive Monitoring and Regulation of Acute Pancreatitis Induced Acute Lung Injury.生物活性纳米材料:急性胰腺炎诱导的急性肺损伤的综合监测与调控
Int J Nanomedicine. 2025 Jul 31;20:9517-9558. doi: 10.2147/IJN.S514653. eCollection 2025.
5
Advances in Liposomal Drug Delivery: Multidirectional Perspectives on Overcoming Biological Barriers.脂质体药物递送的进展:克服生物屏障的多方向视角
Pharmaceutics. 2025 Jul 5;17(7):885. doi: 10.3390/pharmaceutics17070885.
6
Bridging the Regulatory Divide: A Dual-Pathway Framework Using SRA Approvals and AI Evaluation to Ensure Drug Quality in Developing Countries.弥合监管差距:一种利用SRA批准和人工智能评估的双路径框架,以确保发展中国家的药品质量。
Pharmaceuticals (Basel). 2025 Jul 10;18(7):1024. doi: 10.3390/ph18071024.
7
Engineered hybrid cell membrane nanosystems for treating cardiovascular diseases.用于治疗心血管疾病的工程化杂交细胞膜纳米系统。
Mater Today Bio. 2025 Jun 17;33:101992. doi: 10.1016/j.mtbio.2025.101992. eCollection 2025 Aug.
8
Intranasal administration of temozolomide conjugated nanoparticles with transcranial magnetic stimulation improves the survival in glioblastoma xenograft models.经鼻给予与经颅磁刺激相结合的替莫唑胺共轭纳米颗粒可提高胶质母细胞瘤异种移植模型的生存率。
Drug Deliv Transl Res. 2025 Jul 8. doi: 10.1007/s13346-025-01895-9.
9
Synthesis and Characterization of Poly(Lactic-Co-Glycolic Acid)-Paclitaxel (PLGA-PTX) Nanoparticles Evaluated in Ovarian Cancer Models.聚乳酸-乙醇酸共聚物-紫杉醇(PLGA-PTX)纳米颗粒的合成与表征及其在卵巢癌模型中的评估
Pharmaceutics. 2025 May 23;17(6):689. doi: 10.3390/pharmaceutics17060689.
10
Advances in CRISPR-Cas9 in lineage tracing of model animals.CRISPR-Cas9在模式动物谱系追踪中的进展。
Animal Model Exp Med. 2025 Jun;8(6):1004-1022. doi: 10.1002/ame2.70033. Epub 2025 Jun 10.